Unicef South Sudan Pharmaceutical Import Profile — Kenya (DGFT 2022–2026)

Name: Unicef South Sudan Pharmaceutical Import Records from India — 2 Products, $500.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Unicef South Sudan — Pharmaceutical Importer Profile (2026) | 2 Products, $500.0K Trade | TransData Nexus

Unicef South Sudan

Pharmaceutical Importer · Kenya · Antimalarial & Antiparasitic Focus · $500.0K Total Trade · DGFT Verified

Unicef South Sudan is a pharmaceutical importer based in Kenya with a total trade value of $500.0K across 2 products in 1 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Unicef South Sudan sources from 18 verified Indian suppliers, with Micro Labs Limited accounting for 33.7% of imports.

Unicef South Sudan — Import Portfolio & Supplier Network

Unicef South Sudan import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Unicef South Sudan?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Micro Labs Limited	$1.9M	74	33.7%
Medreich Limited	$832.9K	22	14.6%
Ipca Laboratories Limited	$444.7K

What Formulations Does Unicef South Sudan Import?

Formulation	Value	Ships
Amoxicillin dispersible tablets 250 MG	$379.2K	8
Amoxicillin dispersible tablets 250 MG	$346.8K	7
Povidone iodine 10% topical solution	$200.0K	4
Pharmaceutical goods/harmless medicinesmiloxy suspension Each 5ML reconstituedsuspension cont. amoxicillin	$180.7K	13
Amoxicillin 250 MG dispersible tablets	$150.0K	3
Amoxicillin 250MG dispersible tablets10x10s (194620 packs	$150.0K	3
Amoxicillin 250MG dispersible tablets 10x10s (128910 packs	$150.0K	3
Biopolio (b-opv)2ML bivalent type 1 and3 oral poliomyelitis vaccine(bopv),2ML vial of 20 doses (foc 64000 droppers	$146.4K	3
Amoxicillin 250MG dispersible	$100.0K	2
Pharmaceutical products: albendazole	$100.0K	2
Bivalent (type 1 & type 3) oral	$100.0K	2
Azithromycin tablets USP 250MG (107501	$99.0K	2
Amoxicillin dispersible tablets 250 MG (10x10sx55808) - tax invoice no: 711204507 dtd	$93.0K	3
Amoxicillin dispersible tablets 250MG	$91.6K	4
Artemether 20MG+lumefantrine 120MG	$90.6K	2

Unicef South Sudan imports 115 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Artesunate	Antimalarial & Antiparasitic	$400.0K	8	0.2%	14
2	Quinine	Antimalarial & Antiparasitic	$100.0K	2	0.5%	9

Unicef South Sudan imports 2 pharmaceutical products across 1 categories into Kenya totaling $500.0K.

Unicef South Sudan — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Unicef South Sudan is a humanitarian organization operating in South Sudan, focusing on providing essential services, including healthcare, to vulnerable populations. While its primary operations are based in South Sudan, the organization has established procurement activities in Kenya to facilitate the importation of pharmaceutical products. This strategic approach allows Unicef South Sudan to leverage Kenya's more developed infrastructure and regulatory environment for sourcing medical supplies. The organization collaborates with various suppliers to ensure the availability of essential medicines and medical equipment for its programs in South Sudan.

2Distribution Network

Unicef South Sudan's distribution network is designed to efficiently deliver medical supplies to its operations in South Sudan. By sourcing pharmaceutical products through Kenya, the organization benefits from Kenya's established logistics capabilities, including well-developed ports and transportation networks. This arrangement facilitates the timely and cost-effective movement of goods to South Sudan, ensuring that medical supplies reach their intended destinations without significant delays. The use of Kenya as a procurement hub also allows Unicef South Sudan to navigate the complex regulatory landscape of South Sudan more effectively.

3Industry Role

In Kenya's pharmaceutical supply chain, Unicef South Sudan functions as a specialized importer and distributor, focusing on sourcing and supplying medical products for humanitarian aid in South Sudan. Unlike commercial entities, Unicef South Sudan's procurement activities are driven by humanitarian objectives, aiming to provide essential healthcare services to populations in need. Its role is distinct from that of primary wholesalers or parallel importers operating within Kenya's domestic market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Unicef South Sudan

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Unicef South Sudan's sourcing strategy exhibits a high degree of concentration, with a total import value of $500,000 USD from India across 10 shipments, primarily consisting of two products: Artesunate and Quinine. This focused approach suggests a strategic choice to procure specific, high-demand antimalarial medications essential for its programs. The consistent sourcing from Indian suppliers indicates a stable and reliable relationship, reducing the risks associated with supplier dependency. However, the limited product range may expose the organization to supply chain vulnerabilities if there are disruptions in the production or export of these specific medications.

2Supply Chain Resilience

The resilience of Unicef South Sudan's Indian supply chain is bolstered by its partnerships with multiple Indian pharmaceutical companies, including MICRO LABS LIMITED, MEDREICH LIMITED, and IPCA LABORATORIES LIMITED. This diversification across suppliers enhances the organization's ability to mitigate risks associated with single-source dependency. Additionally, the focus on finished pharmaceutical formulations, rather than raw APIs or bulk drugs, ensures that the products meet the necessary quality standards for direct use in medical treatments. While the reliance on international shipping routes introduces potential vulnerabilities, the established logistics capabilities of Kenya provide a buffer against such risks.

Importing Pharmaceuticals into Kenya — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Kenya

1Regulatory Authority & Framework

In Kenya, the Pharmacy and Poisons Board (PPB) serves as the primary regulatory authority overseeing the importation, distribution, and sale of pharmaceutical products. The PPB is responsible for ensuring that all medical products meet the required quality, safety, and efficacy standards before they enter the Kenyan market. Key legislation governing pharmaceutical imports includes the Pharmacy and Poisons Act, which outlines the procedures for product registration, importation, and distribution. For Indian generics to be marketed in Kenya, they must undergo a registration process with the PPB, which involves submitting product samples and documentation to verify compliance with Kenyan standards.

2Import Licensing & GMP

Importers of pharmaceutical products into Kenya are required to obtain an import license from the PPB for each consignment. This process involves submitting an import declaration form through the Kenya National TradeNet System (KESWS). Additionally, imported pharmaceutical products must meet Good Manufacturing Practice (GMP) standards recognized by the PPB. While the PPB does not specify particular GMP certifications, adherence to internationally recognized standards, such as WHO GMP, is generally accepted. Importers must ensure that their suppliers hold valid GMP certificates to facilitate the importation process.

Unicef South Sudan — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Unicef South Sudan's focus on importing antimalarial medications, specifically Artesunate and Quinine, aligns with the organization's mission to combat malaria, a prevalent and life-threatening disease in South Sudan. The high import value of Artesunate ($400,000) and Quinine ($100,000) underscores the critical demand for these treatments. The organization's strategic sourcing from India leverages the country's robust pharmaceutical manufacturing capabilities, ensuring access to quality medications at competitive prices. This approach enables Unicef South Sudan to provide effective malaria treatment options to the populations it serves.

2Sourcing Profile

Unicef South Sudan's sourcing strategy emphasizes the procurement of generic antimalarial medications from India, capitalizing on the country's extensive experience in producing high-quality generics. The focus on finished pharmaceutical formulations ensures that the products are ready for immediate use, streamlining the supply chain and reducing lead times. India's established reputation in the global pharmaceutical market makes it a reliable partner for Unicef South Sudan's procurement needs, aligning with the organization's objectives to provide essential healthcare services efficiently.

3Market Positioning

Seller's Guide — How to Become a Supplier to Unicef South Sudan

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Unicef South Sudan by offering high-quality antimalarial medications that meet the PPB's regulatory standards. Expanding the product range to include other essential medicines could further enhance the organization's ability to address the diverse healthcare needs of South Sudan's population. However, potential suppliers must navigate the regulatory landscape, ensuring compliance with Kenyan import regulations and the PPB's requirements to establish successful partnerships.

2Requirements & Qualifications

Indian exporters seeking to supply Unicef South Sudan and the Kenyan market must ensure that their pharmaceutical products are registered with the PPB and comply with Kenyan import regulations. This includes obtaining the necessary import licenses, adhering to GMP standards recognized by the PPB, and ensuring that labeling and packaging meet the PPB's requirements. Additionally, products must undergo batch testing and meet stability requirements to ensure quality and safety. Compliance with these standards is essential for successful market entry and distribution in Kenya.

3How to Approach

Frequently Asked Questions — Unicef South Sudan

What products does Unicef South Sudan import from India?

Unicef South Sudan imports 2 pharmaceutical products across 1 categories. Top imports: Artesunate ($400.0K), Quinine ($100.0K).

Who supplies pharmaceuticals to Unicef South Sudan from India?

Unicef South Sudan sources from 18 verified Indian suppliers. The primary supplier is Micro Labs Limited (33.7% of imports, $1.9M).

What is Unicef South Sudan's total pharmaceutical import value?

Unicef South Sudan's total pharmaceutical import value from India is $500.0K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Unicef South Sudan focus on?

Unicef South Sudan imports across 1 categories. The largest: Antimalarial & Antiparasitic (100.0%).

Get Full Unicef South Sudan Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.